Saturday, February 10, 2018 4:06:46 AM
Form SC 13G/A DEPOMED INC Filed by: VANGUARD GROUP INC
10:27 AM ET, 02/09/2018 - US Securities and Exchange Commission
http://archive.fast-edgar.com/20180209/AS2ZC622Z222SZE8222A2ZN238MTZ322Z3A2
Filed on: February 9, 2018
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Vanguard Group - 23-1945930
Item 4 - Ownership:
(a) Amount Beneficially Owned:
4,150,419
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM